|
US565354A
(en)
|
|
1896-08-04 |
|
James h |
|
US2842049A
(en)
|
1954-09-22 |
1958-07-08 |
Technicolor Corp |
Deacetylated chitin mordant
|
|
JPS5452794A
(en)
|
1977-09-30 |
1979-04-25 |
Kousaku Yoshida |
Extracting of polysacchride from capusle containing epidermis staphylococus
|
|
US4285936A
(en)
|
1979-12-10 |
1981-08-25 |
The United States Of America As Represented By The Secretary Of The Army |
Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa
|
|
JPS5686121A
(en)
|
1979-12-14 |
1981-07-13 |
Teijin Ltd |
Antitumor proten complex and its preparation
|
|
US4355023A
(en)
|
1980-09-30 |
1982-10-19 |
The Massachusetts General Hospital |
Antibody fragment compositions and process
|
|
US4443549A
(en)
|
1981-10-19 |
1984-04-17 |
Molecular Genetics, Inc. |
Production of monoclonal antibodies against bacterial adhesins
|
|
US4470925A
(en)
|
1982-05-05 |
1984-09-11 |
E. I. Du Pont De Nemours And Company |
Immunoglobulin half-molecules and process for producing hybrid antibodies
|
|
US4462334A
(en)
|
1982-08-19 |
1984-07-31 |
Kim Ho K |
Solar animal structure
|
|
US4465776A
(en)
|
1982-09-27 |
1984-08-14 |
Research Corporation |
Monoclonal antibodies to vitamin B6 and immunoassay method
|
|
US4652448A
(en)
|
1982-10-07 |
1987-03-24 |
Molecular Genetics, Inc. |
Use of monoclonal antibodies against bacterial adhesins
|
|
US4578458A
(en)
|
1983-03-23 |
1986-03-25 |
Brigham And Women's Hospital |
Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa
|
|
DK219084D0
(da)
|
1984-05-02 |
1984-05-02 |
Frederik Carl Peter Lindberg |
Antigen
|
|
JPS6191131A
(ja)
|
1984-10-09 |
1986-05-09 |
Chugai Pharmaceut Co Ltd |
医薬品の吸着防止方法および組成物
|
|
GB8426463D0
(en)
|
1984-10-19 |
1984-11-28 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
|
NZ214503A
(en)
|
1984-12-20 |
1990-02-26 |
Merck & Co Inc |
Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
|
|
FR2581877B1
(fr)
|
1985-05-14 |
1987-12-18 |
Louvain Universite Catholique |
Conjugue constitue d'une adhesine de paroi de s. mutans, de nature proteique et d'un polysaccharide de s. mutans, sa preparation et son utilisation notamment dans des vaccins anti-caries
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US4755381A
(en)
|
1986-03-27 |
1988-07-05 |
Swiss Serum And Vaccine Institute Berne |
Klebsiella capsular polysaccharide vaccine
|
|
US4786592A
(en)
|
1986-06-18 |
1988-11-22 |
Scripps Clinic And Research Foundation |
Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
|
|
US5589591A
(en)
|
1986-07-03 |
1996-12-31 |
Advanced Magnetics, Inc. |
Endotoxin-free polysaccharides
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
GB8621910D0
(en)
|
1986-09-11 |
1986-10-15 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
|
FR2619122B1
(fr)
|
1987-08-03 |
1990-03-09 |
Pasteur Institut |
Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
|
|
US4859449A
(en)
|
1987-09-14 |
1989-08-22 |
Center For Molecular Medicine And Immunology |
Modified antibodies for enhanced hepatocyte clearance
|
|
CA1340506C
(en)
|
1987-11-24 |
1999-04-20 |
Nicholas H. Carbonetti |
Production of gonorrheal pi proteins and vaccines
|
|
US5204098A
(en)
|
1988-02-16 |
1993-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polysaccharide-protein conjugates
|
|
US5055455A
(en)
|
1988-09-28 |
1991-10-08 |
Brigham And Women's Hospital |
Capsular polysaccharide adhesin antigen, preparation, purification and use
|
|
FR2640628A1
(fr)
|
1988-12-16 |
1990-06-22 |
Commissariat Energie Atomique |
Oligosaccharides lies (beta)-(1 -> 6) en particulier des 2-acetamido-2-desoxy-glucoses ou - galactoses et leur preparation
|
|
JP3436756B2
(ja)
|
1988-12-19 |
2003-08-18 |
アメリカン・サイアナミド・カンパニー |
髄膜炎菌のクラスｉの外膜タンパク質のワクチン
|
|
CA2039789A1
(en)
|
1990-04-27 |
1991-10-28 |
Samuel J. Danishefsky |
Calicheamicinone, derivatives and analogs thereof and methods of making the same
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5571511A
(en)
|
1990-10-22 |
1996-11-05 |
The U.S. Government |
Broadly reactive opsonic antibodies that react with common staphylococcal antigens
|
|
US5763191A
(en)
|
1990-12-12 |
1998-06-09 |
Boehringer Mannheim Gmbh |
Universal binding film
|
|
DE4219159A1
(de)
*
|
1992-06-11 |
1993-12-16 |
Boehringer Mannheim Gmbh |
Selbst assemblierende Monoschicht mit kurzkettigen Linkern
|
|
US5352670A
(en)
|
1991-06-10 |
1994-10-04 |
Alberta Research Council |
Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
|
|
DK0594743T3
(da)
|
1991-07-12 |
1999-12-20 |
Pfizer |
Kontinuert cellelinje og vaccine mod aviær coccidia
|
|
DE69233012T2
(de)
|
1991-11-22 |
2003-11-06 |
Fattom, Ali Ibrahim |
Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
|
|
US5872215A
(en)
|
1991-12-02 |
1999-02-16 |
Medical Research Council |
Specific binding members, materials and methods
|
|
ATE156368T1
(de)
|
1991-12-06 |
1997-08-15 |
North Shore Univ Hospital |
Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
|
|
DK0635132T4
(da)
|
1992-03-19 |
2008-08-25 |
Jackson H M Found Military Med |
Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener
|
|
US5425946A
(en)
|
1992-08-31 |
1995-06-20 |
North American Vaccine, Inc. |
Vaccines against group C Neisseria meningitidis
|
|
US5688516A
(en)
|
1992-11-12 |
1997-11-18 |
Board Of Regents, The University Of Texas System |
Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
|
|
US5362754A
(en)
|
1992-11-12 |
1994-11-08 |
Univ. Of Tx Md Anderson Cancer Center |
M-EDTA pharmaceutical preparations and uses thereof
|
|
WO1994015640A1
(en)
|
1993-01-12 |
1994-07-21 |
Anthony George Gristina |
Methods and compositions for the direct concentrated delivery of passive immunity
|
|
US5718694A
(en)
|
1993-11-09 |
1998-02-17 |
The Board Of Regents Of The University Of Nebraska |
Inhibition of adherence of microorganisms to biomaterial surfaces by treatment with carbohydrates
|
|
US5858350A
(en)
|
1993-12-01 |
1999-01-12 |
Marine Polymer Technologies |
Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
|
|
CZ292061B6
(cs)
|
1994-03-17 |
2003-07-16 |
Merck Patent Gmbh |
Jednořetězcové fragmenty protilátek a protilátky proti receptoru epidermálního růstového faktoru, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
|
|
US5534615A
(en)
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
|
JPH0840932A
(ja)
|
1994-07-29 |
1996-02-13 |
Kitasato Inst:The |
スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
|
|
CA2168509A1
(en)
|
1995-02-13 |
1996-08-14 |
Gregory C. Stalcup |
Orthopaedic milling guide with cutter lockout
|
|
AU7339996A
(en)
|
1995-11-06 |
1997-05-29 |
Chugai Seiyaku Kabushiki Kaisha |
Sydnone imine derivatives
|
|
US5830539A
(en)
|
1995-11-17 |
1998-11-03 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Methods for functionalizing and coating substrates and devices made according to the methods
|
|
US6677164B1
(en)
*
|
1995-11-21 |
2004-01-13 |
Novartis Ag |
Multivalent polymers, processes for their preparation, and their use for preparing biologically active compounds
|
|
US6245735B1
(en)
|
1996-07-29 |
2001-06-12 |
The Brigham And Women's Hospital, Inc. |
Methods and products for treating pseudomonas infection
|
|
US6294177B1
(en)
|
1996-09-11 |
2001-09-25 |
Nabi |
Staphylococcus aureus antigen-containing whole cell vaccine
|
|
SK40599A3
(en)
|
1996-09-26 |
2000-06-12 |
Chugai Pharmaceutical Co Ltd |
Antibody against human parathormone related peptides
|
|
CA2284729A1
(en)
*
|
1997-04-18 |
1998-10-29 |
Novartis Ag |
Neoglycoproteins
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
TW586934B
(en)
|
1997-05-19 |
2004-05-11 |
Sumitomo Pharma |
Immunopotentiating composition
|
|
US5989542A
(en)
|
1997-08-20 |
1999-11-23 |
Brigham And Women's Hospital, Inc. |
Capsular polysaccharides from enterococci
|
|
IT1298539B1
(it)
|
1998-02-03 |
2000-01-12 |
Bracco Spa |
Metodo per la determinazione di infezioni da protesi
|
|
US7018637B2
(en)
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
|
CA2264970A1
(en)
|
1998-03-10 |
1999-09-10 |
American Cyanamid Company |
Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria
|
|
JP2002511259A
(ja)
|
1998-04-09 |
2002-04-16 |
ジェンセット |
５’ｅｓｔおよびコードされるヒトタンパク質
|
|
US7214487B2
(en)
|
1998-06-26 |
2007-05-08 |
Sunesis Pharmaceuticals, Inc. |
Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates
|
|
AU4919699A
(en)
|
1998-07-11 |
2000-02-01 |
Mhm Holdings Limited |
Vehicle seat, vehicle seat table and vehicle communication system
|
|
EP1096952B1
(en)
|
1998-07-15 |
2008-05-21 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
US7252828B2
(en)
|
1998-07-15 |
2007-08-07 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
CA2356849C
(en)
|
1998-12-16 |
2008-06-03 |
Sca Hygiene Products Zeist B.V. |
Acidic superabsorbent polysaccharides
|
|
ES2275499T3
(es)
|
1999-03-19 |
2007-06-16 |
Glaxosmithkline Biologicals S.A. |
Vacuna contra streptococcus pneumoniae.
|
|
WO2002094983A2
(en)
|
2001-05-16 |
2002-11-28 |
The Children's Hospital Of Philadelphia |
Dna-antibody complexes to enhance gene transfer
|
|
US6962813B2
(en)
|
2001-05-21 |
2005-11-08 |
The Brigham And Women's Hospital, Inc. |
P. aeruginosa mucoid exopolysaccharide specific binding peptides
|
|
US7119172B2
(en)
|
2001-05-21 |
2006-10-10 |
The Brigham And Women's Hospital, Inc. |
P. aeruginosa mucoid exopolysaccharide specific binding peptides
|
|
US20030113350A1
(en)
|
2001-09-19 |
2003-06-19 |
Fattom Ali I. |
Glycoconjugate vaccines for use in immune-compromised populations
|
|
CN1344722A
(zh)
|
2001-10-19 |
2002-04-17 |
北京盈富安信科技有限公司 |
1→6连接的氨基葡聚寡糖和糖苷及其合成和应用
|
|
AU2002351208A1
(en)
|
2001-12-03 |
2003-06-17 |
Abgenix, Inc. |
Antibodies against carbonic anhydrase IX (CA IX) tumor antigen
|
|
JP2005532415A
(ja)
|
2001-12-11 |
2005-10-27 |
メルク エンド カムパニー インコーポレーテッド |
スタフィロコッカス・アウレウスエキソポリサッカライド及び方法
|
|
CA2471849A1
(en)
|
2001-12-28 |
2003-07-17 |
Abgenix, Inc. |
Antibodies against the muc18 antigen
|
|
EP1532175B1
(en)
|
2002-03-22 |
2012-10-17 |
Aprogen, Inc. |
Humanized antibody and process for preparing the same
|
|
CA2480052A1
(en)
|
2002-04-01 |
2003-10-16 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to gmad
|
|
WO2004043405A2
(en)
|
2002-11-12 |
2004-05-27 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
AU2003290867A1
(en)
|
2002-11-12 |
2004-06-03 |
The Brigham And Women's Hospital, Inc. |
Methods and products for treating staphylococcal infections
|
|
BRPI0408167B1
(pt)
|
2003-03-07 |
2014-10-21 |
Wyeth Corp |
Conjugados de polissacarídeo-proteína veículo adesina da superfície estafilocócica para imunização contra infecções nosocomiais
|
|
CA2530363C
(en)
|
2003-06-23 |
2013-05-07 |
Baxter International Inc. |
Carrier proteins for vaccines
|
|
US9928522B2
(en)
|
2003-08-01 |
2018-03-27 |
Oath (Americas) Inc. |
Audience matching network with performance factoring and revenue allocation
|
|
JP2007501888A
(ja)
|
2003-08-12 |
2007-02-01 |
リポクセン テクノロジーズ リミテッド |
ポリシアル酸誘導体
|
|
AU2005236068C1
(en)
|
2004-04-21 |
2012-08-30 |
Beth Israel Deaconess Medical Center, Inc. |
Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
|
|
CA2475736A1
(en)
*
|
2004-07-23 |
2006-01-23 |
Cyrille Grandjean |
Vibrio cholerae lps detoxified derivatives and immunogenic compositions containing them
|
|
KR20070058631A
(ko)
|
2004-09-22 |
2007-06-08 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
면역원성 조성물
|
|
GB0426394D0
(en)
|
2004-12-01 |
2005-01-05 |
Health Prot Agency |
Fusion proteins
|
|
PL1819359T3
(pl)
*
|
2004-12-09 |
2015-08-31 |
Janssen Biotech Inc |
Immunokoniugaty skierowane przeciw integrynie, metody ich wytwarzania oraz ich zastosowanie
|
|
US20060134141A1
(en)
|
2004-12-14 |
2006-06-22 |
Nabi Biopharmaceuticals |
Glycoconjugate vaccines containing peptidoglycan
|
|
EP1863536A4
(en)
|
2005-03-14 |
2011-07-20 |
Univ Alberta |
VACCINE BASED ON SYNTHETIC OLIGOSACCHARIDES AGAINST CANDIDA ALBICANS
|
|
GB0505996D0
(en)
*
|
2005-03-23 |
2005-04-27 |
Glaxosmithkline Biolog Sa |
Fermentation process
|
|
MY148405A
(en)
|
2006-03-30 |
2013-04-30 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
AR060187A1
(es)
|
2006-03-30 |
2008-05-28 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica
|
|
AU2007257436B2
(en)
|
2006-06-02 |
2013-05-02 |
Synedgen, Inc. |
Chitosan-derivative compounds and methods of controlling microbial populations
|
|
CN100521341C
(zh)
|
2006-08-30 |
2009-07-29 |
三洋电机株式会社 |
燃料电池及燃料电池用燃料供给装置
|
|
KR20110031393A
(ko)
|
2008-07-21 |
2011-03-25 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
|
|
US8454979B2
(en)
|
2009-02-20 |
2013-06-04 |
Meisho Co., Ltd. |
Immunopotentiating composition and process for producing same
|
|
AU2011258165B2
(en)
|
2010-05-26 |
2016-11-17 |
Selecta Biosciences, Inc. |
Dose selection of adjuvanted synthetic nanocarriers
|
|
WO2012099805A2
(en)
|
2011-01-19 |
2012-07-26 |
Ocean Nanotech, Llc |
Nanoparticle based immunological stimulation
|
|
EP2854822B1
(en)
|
2012-05-30 |
2020-07-22 |
The Brigham and Women's Hospital, Inc. |
Polysaccharide compositions and methods of use
|
|
US9759721B2
(en)
|
2013-01-22 |
2017-09-12 |
Imicroq, S.L. |
Rapid method for detection of pathogen
|